In the latest trading session, 0.57 million Caribou Biosciences Inc (NASDAQ:CRBU) shares changed hands as the company’s beta touched 2.31. With the company’s most recent per share price at $1.37 changed hands at -$0.06 or -3.94% at last look, the market valuation stands at $124.39M. CRBU’s current price is a discount, trading about -508.03% off its 52-week high of $8.33. The share price had its 52-week low at $1.30, which suggests the last value was 5.11% up since then. When we look at Caribou Biosciences Inc’s average trading volume, we note the 10-day average is 1.63 million shares, with the 3-month average coming to 1.68 million.
Analysts gave the Caribou Biosciences Inc (CRBU) stock a consensus recommendation rating of Buy, calculated at a mean rating of 1.44. If we narrow down to specifics, the data shows that 0 out of 3 analysts rate the stock as a Sell, with a further 0 assigning it an Overweight rating. Of the remaining, 0 recommended CRBU as a Hold, 3 felt it is a Buy and 0 rated the stock as Underweight.
Caribou Biosciences Inc (NASDAQ:CRBU) trade information
Instantly CRBU was in red as seen in intraday trades today. With action -7.18%, the performance over the past five days has been red. The company’s shares are showing year-to-date downside of -13.60%, with the 5-day performance at -7.18% in the red. However, in the 30-day time frame, Caribou Biosciences Inc (NASDAQ:CRBU) is -13.60% down. Looking at the short shares, we see there were 10.8 million shares sold at short interest cover period of 6.76 days.
The consensus price target for the stock as assigned by Wall Street analysts is 3, meaning bulls need an upside of 54.33% from its recent market value. According to analyst projections, CRBU’s forecast low is 3 with 3 as the target high. To hit the forecast high, the stock’s price needs a -118.98% plunge from its current level, while the stock would need to soar -118.98% for it to hit the projected low.
Caribou Biosciences Inc (CRBU) estimates and forecasts
Data shows that the Caribou Biosciences Inc share is performing relatively much not better than most of its peers within the same industry. As can be gleaned from the statistics, the company’s share value shot -38.67% over the past 6 months, a -18.84% in annual growth rate that is considerably lower than the industry average of 15.90%.
Looking at the company’s year-on-year earnings, data shows that the past 5-year has an earnings growth rate of -37.16%. The 2025 estimates are for Caribou Biosciences Inc earnings to decrease by -20.17%, but the outlook for the next 5-year period is at -12.22% per year.
Caribou Biosciences Inc (NASDAQ:CRBU)’s Major holders
If we look at who the major shareholders are, we find that insiders hold 10.04% of Caribou Biosciences Inc shares while 62.13% of the shares are in the hands of institutional holders. The share float percentage for the stock currently stands at 69.06%. There are 62.13% institutions holding the Caribou Biosciences Inc stock share, with BLACKROCK INC. the top institutional holder. As of 2024-06-30, the company held 7.7801% of the shares, roughly 6.95 million CRBU shares worth $11.39 million.
VANGUARD GROUP INC holds the second largest percentage of outstanding shares, with 5.0891% or 4.54 million shares worth $7.45 million as of 2024-06-30.
Among Mutual Funds, the top two as of Sep 30, 2024 were Vanguard Total Stock Market Index Fund and iShares Russell 2000 ETF. With 2.77 shares estimated at $3.83 million under it, the former controlled 3.06% of total outstanding shares. On the other hand, iShares Russell 2000 ETF held about 2.61% of the shares, roughly 2.36 shares worth around $3.27 million.
